NYSE: MCMoelis & Co Stock
$67.86-1.38 (-1.99%)
Updated Jun 5, 2026
MC Price
$67.86
Fair Value Price
N/A
Market Cap
$5.33B
52 Week Low
$51.06
52 Week High
$78.22
P/E
23.08x
P/B
10.95x
P/S
2.89x
PEG
1.6x
Dividend Yield
3.83%
Revenue
$1.53B
Earnings
$221.20M
Gross Margin
100%
Operating Margin
19.85%
Profit Margin
14.5%
Debt to Equity
1.37
Operating Cash Flow
$463M
Beta
1.38
Next Earnings
Jul 30, 2026
Ex-Dividend
N/A
Next Dividend
Jun 18, 2026
MC Overview
Moelis & Company offers advisory services in the areas of mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters in North and South America, Europe, Middle East, Asia, and Australia. It provides services to public multinational corporations, middle market private companies, financial sponsors, entrepreneurs, governments, and sovereign wealth funds. Moelis & Company was founded in 2007 and is headquartered in New York, NY.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine MC's potential to beat the market
DSell
- Stocks with a Zen Rating of Sell (D) had an average loss of -4.50% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important MC news, forecast changes, insider trades & much more!
MC News
Overview
Due Diligence Score
–
Industry Average (30)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how MC scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
MC ($67.86) is trading above its intrinsic value of $30.08, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
MC is poor value based on its earnings relative to its share price (23.08x), compared to the US market average (12.7x)
P/E vs Market Valuation
MC is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more MC due diligence checks available for Premium users.
Valuation
MC price to earnings (PE)
For valuing profitable companies with steady earnings
Company
23.08x
Industry
17.66x
Market
12.7x
MC is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
MC is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
MC price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
10.95x
Industry
2.97x
MC is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
MC price to earnings growth (PEG)
For valuing profitable companies with growth potential
MC is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
MC's financial health
Profit margin
Revenue
$319.8M
Net Income
$38.4M
Profit Margin
12%
MC's Earnings (EBIT) of $303.64M... subscribe to Premium to read more.
Interest Coverage Financials
MC's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.3B
Liabilities
$667.0M
Debt to equity
1.37
MC's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
MC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$278.8M
Investing
$127.6M
Financing
-$204.4M
MC's operating cash flow ($462.98M)... subscribe to Premium to read more.
Debt Coverage Financials
MC vs Capital Market Stocks
Moelis & Co Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.